Zynex, Inc. Stock

Equities

ZYXI

US98986M1036

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 12:33:52 2024-05-09 pm EDT 5-day change 1st Jan Change
10.67 USD -0.56% Intraday chart for Zynex, Inc. -7.50% -1.97%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 227M Sales 2025 * 284M Capitalization 341M
Net income 2024 * 16M Net income 2025 * 30M EV / Sales 2024 * 1.36 x
Net cash position 2024 * 33.22M Net cash position 2025 * 11.12M EV / Sales 2025 * 1.16 x
P/E ratio 2024 *
21.8 x
P/E ratio 2025 *
11.8 x
Employees 1,100
Yield 2024 *
-
Yield 2025 *
-
Free-Float 37.25%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.14%
1 week-8.84%
Current month-2.19%
1 month-14.57%
3 months-12.69%
6 months+18.56%
Current year-1.47%
More quotes
1 week
10.64
Extreme 10.64
11.81
1 month
10.64
Extreme 10.64
12.42
Current year
9.80
Extreme 9.8
13.77
1 year
6.88
Extreme 6.88
13.77
3 years
4.97
Extreme 4.97
17.25
5 years
4.97
Extreme 4.97
27.02
10 years
0.06
Extreme 0.0552
27.02
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 95-12-31
Director of Finance/CFO 51 17-06-04
Chief Operating Officer 38 18-01-31
Members of the board TitleAgeSince
Director/Board Member 74 18-01-09
Chief Executive Officer 65 95-12-31
Director/Board Member 66 18-01-09
More insiders
Date Price Change Volume
24-05-09 10.68 -0.51% 22 183
24-05-08 10.73 -1.92% 64,574
24-05-07 10.94 +1.86% 87,111
24-05-06 10.74 -2.36% 101,985
24-05-03 11 -4.68% 100,926

Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT

More quotes
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.73 USD
Average target price
19.88 USD
Spread / Average Target
+85.23%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW